MARÍA DE LA ALMUDENA
GÓMEZ HERNÁNDEZ
Profesora titular de universidad
![Foto de MARÍA DE LA ALMUDENA](/img/nophoto.png)
![Foto de Fundación Jiménez Díaz](/img/noimage_org.png)
Fundación Jiménez Díaz
Madrid, EspañaPublicacions en col·laboració amb investigadors/es de Fundación Jiménez Díaz (9)
2018
-
Potential role of insulin receptor isoforms and IGF receptors in plaque instability of human and experimental atherosclerosis
Cardiovascular Diabetology, Vol. 17, Núm. 1
2016
-
Expression of insulin receptor (IR) A and B isoforms, IGF-IR, and IR/IGF-IR hybrid receptors in vascular smooth muscle cells and their role in cell migration in atherosclerosis
Cardiovascular Diabetology, Vol. 15, Núm. 1
2009
-
Leukotriene B4 enhances the activity of nuclear factor-κB pathway through BLT1 and BLT2 receptors in atherosclerosis
Cardiovascular Research, Vol. 81, Núm. 1, pp. 216-225
2007
-
Licofelone, a balanced inhibitor of cyclooxygenase and 5-lipoxygenase, reduces inflammation in a rabbit model of atherosclerosis
Journal of Pharmacology and Experimental Therapeutics, Vol. 320, Núm. 1, pp. 108-116
2006
-
Atorvastatin reduces the expression of prostaglandin E2 receptors in human carotid atherosclerotic plaques and monocytic cells: Potential implications for plaque stabilization
Journal of Cardiovascular Pharmacology, Vol. 47, Núm. 1, pp. 60-69
-
Overexpression of COX-2, Prostaglandin E Synthase-1 and Prostaglandin E Receptors in blood mononuclear cells and plaque of patients with carotid atherosclerosis: Regulation by nuclear factor-κB
Atherosclerosis, Vol. 187, Núm. 1, pp. 139-149
2005
-
HMG-CoA reductase inhibitors reduce IκB kinase activity induced by oxidative stress in monocytes and vascular smooth muscle cells
Journal of Cardiovascular Pharmacology, Vol. 45, Núm. 5, pp. 468-475
-
Intensive treatment with atorvastatin reduces inflammation in mononuclear cells and human atherosclerotic lesions in one month
Stroke, Vol. 36, Núm. 8, pp. 1796-1800